Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Clinicoeconomics and Outcomes Research : CEOR|February 22, 2019
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patientMarie Fournier, Chieh-I Chen, Andreas Kuznik, et al.Pharmacoeconomics|May 19, 2011
Cost estimation of cardiovascular disease events in the USAmy K O'Sullivan, Jaime Rubin, Joshua Nyambose, et al.Toxicon : Official Journal of the International Society on Toxinology|December 31, 2018
Snakebite burden in Sub-Saharan Africa: estimates from 41 countriesSadiq Halilu, Garba Iliyasu, Muhammad Hamza, et al.Ophthalmology and Therapy|May 19, 2026
Summary of Research: Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the USAndreas Kuznik, Anna Coughlan, Amy Pinsent, et al.Clinicoeconomics and Outcomes Research : CEOR|December 9, 2020
Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of COVID-19Ning Wu, Andreas Kuznik, Degang Wang, et al.Mayo Clinic Proceedings|December 3, 2008
Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiatedTerry A Jacobson, Debra A Wertz, Tracey Hoy, et al.AIDS (London, England)|September 24, 2016
Initiation of antiretroviral therapy based on the 2015 WHO guidelinesAndreas Kuznik, Garba Iliyasu, Abdulrazaq G Habib, et al.European Journal of Preventive Cardiology|June 14, 2023
Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemiaJing Gu, Andreas Kuznik, Peter Quon, et al.Journal of Managed Care Pharmacy : JMCP|December 31, 2013
Moving branded statins to lowest copay tier improves patient adherenceShih-Yin Chen, Sonali N Shah, Yuan-Chi Lee, et al.American Health & Drug Benefits|November 23, 2018
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted TherapyMachaon M K Bonafede, Donna McMorrow, Clare Proudfoot, et al.Pageof 8